Pharma
Despite FDA crackdown, unapproved GLP-1s still threaten the industry
Legitimate compounders are threatened by false advertising of counterfeit GLP-1s, legal experts warn.
Regulations & Drug Approval
Deep dives into Regulations & Drug Approval and its impact on healthcare. From International Regulation and Compliance & Safety Monitoring to industry-wide shifts, Healthcare Brew covers the essential developments in Pharma.
Pharma
Could relaxed regulations boost gene therapy for ultra-rare diseases?
Companies like Prime Medicine and Aurora Therapeutics are shooting their shot.
Pharma
What new advertising rules may mean for pharma companies
The Trump administration’s crackdown on direct-to-consumer pharma ads could make TV advertising “very expensive and very difficult,” one expert said.
Pharma
Sarepta to cut 36% of staff, add black-box warning to Elevidys
The layoffs come after two deaths of patients who had taken its most profitable product, Elevidys.
Pharma
Pharma has laid off thousands in H1 2025
The first half of the year has been…eventful, to say the least.
Pharma
Pharma tariffs are coming ‘very shortly.’ Here’s how they could impact healthcare
Companies are likely to see cost increases despite an initial exemption.
Pharma
Sarepta’s gene therapy faced internal FDA doubts. Now, a teen has died
The death is heating up concerns around the FDA’s approval process.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
